|
Communique — Documents — Home
This page contains links to external Web sites. The Treatment Improvement Exchange has no control over their content or availability.
Societal Outcomes and Cost Savings from AOD Treatment
Jeffrey N. Kushner, Drug Court Administrator for the 22nd Judicial Circuit, St. Louis, Missouri, and former Director,
Office of Alcohol and Drug Abuse Programs, Oregon Department of Human Resources.
Most State legislatures are not
convinced about the "goodness" of
alcohol and other drug (AOD) treatment by reviewing either national research
data or studies completed in other States. State legislatures want data from
the State treatment system they are funding. This can be a problem from
several standpoints, not the least of which is the onerous cost of follow-up
studies that depend on personal interviews. And how accurate are they, really?
Over the past 30 years, there have been a number of studies
involving economic analyses of the benefits and costs of drug and/or alcohol
treatment.1 The usefulness of their
results has often been weakened by limitations in their methodologies.
These study limitations include the following:
Lack of a comparison or control group
Failure to use a representative sampling design in selecting subjects
Exclusive use of self-reported data
Brief observation periods (usually focused on the time just before
or just after treatment not necessarily representative periods)
Use of limited populations (for example, enrollees in an HMO)
Assessment of costs and benefits only in a limited number of areas
Oregon's Study Approach
Oregon decided to take a different approach. A study that would
use Oregon-specific outcome data was chosen as a result of interest from
the Governor's Council on Alcohol and Drug Abuse Programs and a
nudge from the Oregon Legislative Assembly. The total cost of this study was
approximately $30,000. No specific funding was provided.
The Oregon study was designed to overcome some of the
methodological limitations of prior studies that
have looked at benefits and costs of drug and/or alcohol treatment. Its
study design has the following characteristics:
We selected a representative sample of clients who had
completed treatment and matched them with a comparison group of
clients who received little or no treatment.
We used existing State agency databases rather than
self-report data; these databases provided for maximum objectivity.
We utilized an adequate study period, which covered 2 years prior
to treatment and 3 years subsequent to the completion of treatment.
Study Design
Using a quasi-experimental design, groups of clients who had
completed treatment were compared with groups of clients who had enrolled in
treatment programs but terminated after receiving only minimal services.
In order to have up to 3 years of post-treatment outcome data, the
sample was drawn from fiscal year 1991-92.
Using the Client Process Monitoring System (CPMS) database, a
representative random sample of clients was selected for each service element
outpatient, residential, and methadone. The CPMS database is the
Oregon management information system for alcohol and/or drug treatment
programs that receive public funds (built off the old CODAP system). Programs
must report on clients at intake and at termination.
A comparison group was randomly selected. This group was made up
of clients who began treatment but did not follow through in keeping
appointments. The comparison group was matched to the treatment
completers, so that no differences existed between the groups in age, gender, race,
drug type, or severity of drug abuse. Based on a power analysis of the
needed sample size, we set a target of 250 treatment and 250 comparison
clients for each module, outpatient and residential. A total of 1,267 clients
was originally selected for the study sample.
Use of Existing Databases
To collect outcome data for these clients from the periods prior and
subsequent to their treatment episodes, we used existing State databases.
We gained permission to access these databases and protected the
confidentiality of clients at all times. These State databases included the following:
Client Process Monitoring System
Law Enforcement Data System
Offender Profile System
Adult and Family Services
Office of Medical Assistance Programs (Medicaid)
Children's Services Division
Outcome Study Results
Oregon's study found extensive cost savings on a variety of dimensions
for clients who had successfully completed their AOD treatment.
Significant cost savings occurred because of the reductions in arrests and
convictions, incarceration, use of welfare benefits, open child welfare
cases, emergency room medical costs, and because of an improvement in
clients' earning power and number of days worked. For every dollar spent
on treatment, taxpayers saved $5.60 in avoided costs.
Even this figure is most
conservative for the following reasons:
The study includes no cost savings from the clients' decrease in
unemployment.
Some benefit can be assumed to accrue for those
comparison-group clients who were treated for
weeks and/or months but did not complete treatment. These savings are
not represented in this study.
Other potential cost avoidances
are not included. For example, savings were realized because many
clients avoided problems that would otherwise have exacted public and
private funds, such as Federal and local prison costs,
institutional costs, damage caused by intoxicated drivers, business losses,
and the birth of healthy rather than drug-affected babies.
Copies of the study Societal
Outcomes and Cost Savings of Drug and Alcohol Treatment in the State of
Oregon are available from the Oregon Office of Alcohol and Drug Abuse
Programs. To order, call Clint Goff, at (503) 945-5763.
| Results of Oregon's State-Specific Outcome Study |
AOD treatment completers had significantly fewer arrests and convictions in the 3 years after treatment than
early leavers, even though there were no statistically significant differences in their arrest and conviction histories prior
to treatment. Clients who completed outpatient treatment were arrested at a rate 45 percent lower than the matched group.
Treatment completion is associated with substantially fewer incarcerations in State prison and with shorter
incarcerations. Clients who completed residential treatment were jailed at a 70 percent lower rate than the matched group.
Treatment completers earned 65 percent more than noncompleters, due to higher wages and increased time at work.
Clients who completed treatment reduced their use of food stamps by one third in contrast to the comparison group.
For clients who completed treatment, the number of open child welfare cases decreased by 50 percent.
Medical expenses dropped substantially for treatment completers compared with the control group. Early leavers
dramatically increased their use of hospital emergency rooms.
Savings of $83,147,187 in avoided criminal justice, medical, and public assistance costs, and in victim and theft
losses were realized for the 1991_92 cohort of treatment completers in the 2½ years following treatment. The cost for
AOD treatment for all adults in 1991_92 was
$14,879,128.
Overall, significant positive societal outcomes resulting from AOD treatment accrued and lasted for at least 3 years. |
1For a thorough examination of all but
the most recent research, the reader is referred to: President's Commission on Model
State Drug Laws, Socioeconomic Evaluations of Addictions Treatment,
by the Center of Alcohol Studies at Rutgers University. The
White House: Washington, DC, 1993.
 
Table of Contents
Last Updated
|